A detailed history of Eagle Health Investments LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Eagle Health Investments LP holds 233,089 shares of PRCT stock, worth $18.9 Million. This represents 3.54% of its overall portfolio holdings.

Number of Shares
233,089
Previous 257,089 9.34%
Holding current value
$18.9 Million
Previous $15.7 Million 18.89%
% of portfolio
3.54%
Previous 2.76%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.31 - $84.99 $1.35 Million - $2.04 Million
-24,000 Reduced 9.34%
233,089 $18.7 Million
Q2 2024

Aug 13, 2024

SELL
$45.73 - $69.19 $3.66 Million - $5.54 Million
-80,129 Reduced 23.76%
257,089 $15.7 Million
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $1.42 Million - $1.96 Million
53,000 Added 18.65%
337,218 $11.9 Million
Q1 2023

May 12, 2023

BUY
$26.64 - $39.74 $7.57 Million - $11.3 Million
284,218 New
284,218 $8.07 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.